Hepatitis C: the clinical spectrum of the disease

J Hepatol. 1999;31 Suppl 1:9-16. doi: 10.1016/s0168-8278(99)80368-7.

Abstract

The hepatitis C virus (HCV) infects nearly 170 million people worldwide and is responsible for approximately 20% of cases of acute hepatitis and 70% of cases of chronic hepatitis. Acute hepatitis is icteric in only 20% of patients and is rarely severe. Eighty-five percent of infected patients develop chronic infection which is generally asymptomatic, resulting in most cases in fortuitous diagnosis, which may be made at a late stage. Twenty-five percent of the HCV chronic carriers have persistently normal serum alanine aminotransferase (ALT) levels despite having detectable HCV RNA in serum; 75% have elevated ALT levels. The former patients usually have mild histologic lesions, probably with a good long-term prognosis. In the latter patients, a liver biopsy is the most accurate way to distinguish patients with mild chronic hepatitis from those with moderate or severe chronic hepatitis. While most patients with mild chronic hepatitis have a slowly progressive liver disease, the patients with moderate or severe chronic hepatitis may develop cirrhosis within a few years. In patients with HCV-related cirrhosis, the incidence of hepatocellular carcinoma is 2-5% per year. At presently, HCV-related end-stage cirrhosis is the first cause of liver transplantation.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Alanine Transaminase / blood
  • Carcinoma, Hepatocellular / virology
  • Hepatitis C / blood
  • Hepatitis C / complications
  • Hepatitis C / diagnosis*
  • Hepatitis C, Chronic / blood
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / diagnosis
  • Humans
  • Liver Cirrhosis / virology
  • Liver Neoplasms / virology
  • Severity of Illness Index

Substances

  • Alanine Transaminase